Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2020

01-12-2020 | Osteoarthrosis | Research article

Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases

Authors: Zhuoran Hu, Shuiming Xu, He Lin, Weifeng Ni, Qingyuan Yang, Jun Qi, Keqian Du, Jieruo Gu, Zhiming Lin

Published in: BMC Musculoskeletal Disorders | Issue 1/2020

Login to get access

Abstract

Backgroud

This study is to explore the prevalence of different stages of bone loss and the potential risk factors in rheumatic patients.

Method

A cross-sectional study recruits 1398 rheumatic patients and 302 healthy subjects. Demographic data, blood, and bone mineral density (BMD) tests are collected. Risk factors for bone loss in rheumatic patients are analyzed by logistic regression.

Results

(1) Rheumatic patients are consisted of 40.0% rheumatoid arthritis (RA), 14.7% systemic lupus erythematosus (SLE), 14.2% osteoarthritis (OA), 9.2% ankylosing spondylosis (AS), 7.9% gout, 7.0% primary Sjogren syndrome (pSS), 3.8% systemic sclerosis (SSc), and 3.2% mixed connective tissue disease (MCTD). (2) In male patients aged under 50 and premenopausal female patients, the bone mineral density score of AS (53.9%, P < 0.001) and SLE (39.6%, P = 0.034) patients is lower than the healthy controls (18.2%). (3) Osteopenia and osteoporosis are more prevailing in male patients aged or older than 50 and postmenopausal female patients with RA (P < 0.001), OA (P = 0.02) and SLE (P = 0.011) than healthy counterparts. (4) Those with SLE, RA and AS gain the highest odd ratio of ‘score below the expected range for age’, osteopenia and osteoporosis, respectively. (5) Age, female, low BMI and hypovitaminosis D are found negatively associated with bone loss. Dyslipidemia and hyperuricemia could be protective factors.

Conclusion

Young patients with AS and SLE have a significant higher occurrence of bone loss, and older patients with RA, OA and SLE had higher prevalence than healthy counterparts. SLE, RA, SSc and AS were founded significant higher risks to develop into bone loss after adjustment. Age, BMI and gender were commonly-associated with bone loss in all age-stratified rheumatic patients. These findings were not markedly different from those of previous studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11.CrossRefPubMed Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11.CrossRefPubMed
2.
go back to reference Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–55.PubMedCrossRef Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–55.PubMedCrossRef
4.
go back to reference Sapir-koren R, Livshits G. Postmenopausal osteoporosis in rheumatoid arthritis : the estrogen de fi ciency-immune mechanisms link. Bone. 2017;103:102–15.PubMedCrossRef Sapir-koren R, Livshits G. Postmenopausal osteoporosis in rheumatoid arthritis : the estrogen de fi ciency-immune mechanisms link. Bone. 2017;103:102–15.PubMedCrossRef
5.
go back to reference Lee SG, Park YE, Park SH, Kim TK, Choi HJ, Lee SJ, et al. Increased frequency of osteoporosis and BMD below the expected range for age among south Korean women with rheumatoid arthritis. Int J Rheum Dis. 2012;15(3):289–96.PubMedCrossRef Lee SG, Park YE, Park SH, Kim TK, Choi HJ, Lee SJ, et al. Increased frequency of osteoporosis and BMD below the expected range for age among south Korean women with rheumatoid arthritis. Int J Rheum Dis. 2012;15(3):289–96.PubMedCrossRef
6.
go back to reference Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A, et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res. 2012;64(12):1871–187 Avouac, J., Koumakis, E., Toth, E, Meunie.CrossRef Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A, et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res. 2012;64(12):1871–187 Avouac, J., Koumakis, E., Toth, E, Meunie.CrossRef
8.
go back to reference Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, et al. Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med. 2016;3(1):e000098.PubMedPubMedCentralCrossRef Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, et al. Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med. 2016;3(1):e000098.PubMedPubMedCentralCrossRef
9.
go back to reference Chen ZY, Kok VC, Hung GD, Horng JT, Kuo JT, Wang MN. Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos Int. 2018;29(4):973–85.PubMedCrossRef Chen ZY, Kok VC, Hung GD, Horng JT, Kuo JT, Wang MN. Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos Int. 2018;29(4):973–85.PubMedCrossRef
10.
go back to reference Kim YH, Lee JS, Park JH. Association between bone mineral density and knee osteoarthritis in Koreans: the fourth and fifth Korea National Health and nutrition examination surveys. Osteoarthr Cartil. 2018;26(11):1511–7.CrossRef Kim YH, Lee JS, Park JH. Association between bone mineral density and knee osteoarthritis in Koreans: the fourth and fifth Korea National Health and nutrition examination surveys. Osteoarthr Cartil. 2018;26(11):1511–7.CrossRef
11.
go back to reference Klingberg E, Lorentzon M, Mellström D, Geijer M, Göthlin J, Hilme E, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108–R.PubMedPubMedCentralCrossRef Klingberg E, Lorentzon M, Mellström D, Geijer M, Göthlin J, Hilme E, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108–R.PubMedPubMedCentralCrossRef
12.
go back to reference Gravani F, Papadaki I, Antypa E, Nezos A, Masselou K, Ioakeimidis D, et al. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations. Arthritis Res Ther. 2015;17(1):1–13.CrossRef Gravani F, Papadaki I, Antypa E, Nezos A, Masselou K, Ioakeimidis D, et al. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations. Arthritis Res Ther. 2015;17(1):1–13.CrossRef
13.
go back to reference Bodolay E, Bettembuk P, Balogh Á, Szekanecz Z. Osteoporosis in mixed connective tissue disease. Clin Rheumatol. 2003;22(3):213–7.PubMedCrossRef Bodolay E, Bettembuk P, Balogh Á, Szekanecz Z. Osteoporosis in mixed connective tissue disease. Clin Rheumatol. 2003;22(3):213–7.PubMedCrossRef
14.
go back to reference Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344(8914):23–7.PubMedCrossRef Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344(8914):23–7.PubMedCrossRef
15.
go back to reference Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol. 1998;25(7):1282–9.PubMed Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol. 1998;25(7):1282–9.PubMed
16.
go back to reference Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol (Hoboken, NJ). 2017;69(8):1521–37.CrossRef Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol (Hoboken, NJ). 2017;69(8):1521–37.CrossRef
17.
go back to reference Axelsson KF, Nilsson AG, Lorentzon M. Alendronate and Hip Fracture in Patients Using Glucocorticoids—Reply. JAMA. 2017;318(17):1712.PubMedCrossRef Axelsson KF, Nilsson AG, Lorentzon M. Alendronate and Hip Fracture in Patients Using Glucocorticoids—Reply. JAMA. 2017;318(17):1712.PubMedCrossRef
18.
go back to reference Rentero ML, Amigo E, Chozas N, Fernández Prada M, Silva-Fernández L, Abad Hernandez MA, et al. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy epidemiology of musculoskeletal disorders. BMC Musculoskelet Disord. 2015;16(1):4–13.CrossRef Rentero ML, Amigo E, Chozas N, Fernández Prada M, Silva-Fernández L, Abad Hernandez MA, et al. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy epidemiology of musculoskeletal disorders. BMC Musculoskelet Disord. 2015;16(1):4–13.CrossRef
19.
go back to reference Wang DM, Zeng QY, Chen SB, Gong Y, Hou ZD, Xiao ZY. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases. Clin Exp Rheumatol. 2015;33(4):465–70.PubMed Wang DM, Zeng QY, Chen SB, Gong Y, Hou ZD, Xiao ZY. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases. Clin Exp Rheumatol. 2015;33(4):465–70.PubMed
20.
go back to reference Papageorgiou M, Dolan E, Elliott-Sale KJ, Sale C. Reduced energy availability: implications for bone health in physically active populations. Eur J Nutr. 2018;57(3):847–59.PubMedCrossRef Papageorgiou M, Dolan E, Elliott-Sale KJ, Sale C. Reduced energy availability: implications for bone health in physically active populations. Eur J Nutr. 2018;57(3):847–59.PubMedCrossRef
21.
go back to reference Kerr C, Bottomley C, Shingler S, Giangregorio L, de Freitas HM, Patel C, et al. The importance of physical function to people with osteoporosis. Osteoporos Int. 2017;28(5):1597–607.PubMedPubMedCentralCrossRef Kerr C, Bottomley C, Shingler S, Giangregorio L, de Freitas HM, Patel C, et al. The importance of physical function to people with osteoporosis. Osteoporos Int. 2017;28(5):1597–607.PubMedPubMedCentralCrossRef
23.
go back to reference Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. Lupus. 2017;26(4):365–72.PubMedCrossRef Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. Lupus. 2017;26(4):365–72.PubMedCrossRef
24.
go back to reference Kilic G, Kilic E, Akgul O, Ozgocmen S. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Int J Rheum Dis. 2016;19(4):405–11.PubMedCrossRef Kilic G, Kilic E, Akgul O, Ozgocmen S. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Int J Rheum Dis. 2016;19(4):405–11.PubMedCrossRef
25.
go back to reference Lee JH, Sung YK, Choi CB, Cho SK, Bang SY, Choe JY, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskeletal Disord. 2016;17(1):98.CrossRef Lee JH, Sung YK, Choi CB, Cho SK, Bang SY, Choe JY, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskeletal Disord. 2016;17(1):98.CrossRef
27.
go back to reference Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.
28.
go back to reference Wildman RP, Gu D, Reynolds K, Duan X, He J. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr. 2004;80(5):1129–36.PubMedCrossRef Wildman RP, Gu D, Reynolds K, Duan X, He J. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr. 2004;80(5):1129–36.PubMedCrossRef
29.
go back to reference World Health Organization. Prevention and management of osteoporosis. World Health Organization technical report series. 2003(921):1–164. World Health Organization. Prevention and management of osteoporosis. World Health Organization technical report series. 2003(921):1–164.
30.
go back to reference Hans D, Downs RW Jr, Duboeuf F, Greenspan S, Jankowski LG, Kiebzak GM, et al. Skeletal sites for osteoporosis diagnosis: the 2005 ISCD official positions. J Clin Densitometry. 2006;9(1):15–21.CrossRef Hans D, Downs RW Jr, Duboeuf F, Greenspan S, Jankowski LG, Kiebzak GM, et al. Skeletal sites for osteoporosis diagnosis: the 2005 ISCD official positions. J Clin Densitometry. 2006;9(1):15–21.CrossRef
31.
go back to reference Subirana I, Sanz H, Vila J. Building Bivariate Tables: The compareGroups Package for R. J Stat Software. 2014;57(12):1–6.CrossRef Subirana I, Sanz H, Vila J. Building Bivariate Tables: The compareGroups Package for R. J Stat Software. 2014;57(12):1–6.CrossRef
32.
go back to reference Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, et al. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int. 2008;28(11):1143–50.PubMedCrossRef Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, et al. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int. 2008;28(11):1143–50.PubMedCrossRef
33.
go back to reference Monte TS, Ruiz JP, Torrente-Segarra V, Mojal S, Padró I, Carbonell J. Prevalence of osteopenia and osteoporosis in women with systemic lupus erythematosus. Ann Rheum Dis. 2013;72(Suppl 3):A920–A1. Monte TS, Ruiz JP, Torrente-Segarra V, Mojal S, Padró I, Carbonell J. Prevalence of osteopenia and osteoporosis in women with systemic lupus erythematosus. Ann Rheum Dis. 2013;72(Suppl 3):A920–A1.
34.
go back to reference Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol. 2006;35(5):384–7.PubMedCrossRef Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol. 2006;35(5):384–7.PubMedCrossRef
35.
go back to reference Geusens PP, van den Bergh JP. Osteoporosis and osteoarthritis: shared mechanisms and epidemiology. Curr Opin Rheumatol. 2016;28(2):97–103.PubMedCrossRef Geusens PP, van den Bergh JP. Osteoporosis and osteoarthritis: shared mechanisms and epidemiology. Curr Opin Rheumatol. 2016;28(2):97–103.PubMedCrossRef
36.
go back to reference Xiao J, Chen W, Feng X, Liu W, Zhang Z, He L, et al. Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years. Clin Interv Aging. 2017;12:445–52.PubMedPubMedCentralCrossRef Xiao J, Chen W, Feng X, Liu W, Zhang Z, He L, et al. Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years. Clin Interv Aging. 2017;12:445–52.PubMedPubMedCentralCrossRef
37.
go back to reference Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ, et al. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metab Clin Exp. 2014;63(1):150–60.PubMedCrossRef Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ, et al. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metab Clin Exp. 2014;63(1):150–60.PubMedCrossRef
39.
go back to reference Wang Y, Zhou R, Zhong W, Hu C, Lu S, Chai Y. Association of gout with osteoporotic fractures. Int Orthop. 2018;42(9):2041–7.PubMedCrossRef Wang Y, Zhou R, Zhong W, Hu C, Lu S, Chai Y. Association of gout with osteoporotic fractures. Int Orthop. 2018;42(9):2041–7.PubMedCrossRef
40.
go back to reference Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH. Gout and the risk of non-vertebral fracture. J Bone Miner Res. 2017;32(2):230–6.PubMedCrossRef Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH. Gout and the risk of non-vertebral fracture. J Bone Miner Res. 2017;32(2):230–6.PubMedCrossRef
41.
go back to reference Kim BJ, Baek S, Ahn SH, Kim SH, Jo MW, Bae SJ, et al. Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporos Int. 2014;25(7):1837–44.PubMedCrossRef Kim BJ, Baek S, Ahn SH, Kim SH, Jo MW, Bae SJ, et al. Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporos Int. 2014;25(7):1837–44.PubMedCrossRef
42.
go back to reference Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR. Low bone density in systemic sclerosis. A systematic review. J Rheumatol. 2013;40(11):1881–90.PubMedCrossRef Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR. Low bone density in systemic sclerosis. A systematic review. J Rheumatol. 2013;40(11):1881–90.PubMedCrossRef
43.
go back to reference Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet's disease and spondyloarthritis on anti-Mullerian hormone levels. Rheumatology (Oxford). 2015;54(9):1709–12.CrossRef Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet's disease and spondyloarthritis on anti-Mullerian hormone levels. Rheumatology (Oxford). 2015;54(9):1709–12.CrossRef
44.
go back to reference Alay I, Kaya C, Cengiz H, Yildiz S, Ekin M, Yasar L. The relation of body mass index, menopausal symptoms, and lipid profile with bone mineral density in postmenopausal women. Taiwan J Obstet Gynecol. 2020;59(1):61–6.PubMedCrossRef Alay I, Kaya C, Cengiz H, Yildiz S, Ekin M, Yasar L. The relation of body mass index, menopausal symptoms, and lipid profile with bone mineral density in postmenopausal women. Taiwan J Obstet Gynecol. 2020;59(1):61–6.PubMedCrossRef
45.
go back to reference Chen YY, Wang WW, Yang L, Chen WW, Zhang HX. Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. Eur Rev Med Pharmacol Sci. 2018;22(1):1–9.PubMed Chen YY, Wang WW, Yang L, Chen WW, Zhang HX. Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. Eur Rev Med Pharmacol Sci. 2018;22(1):1–9.PubMed
46.
go back to reference Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409–47.PubMedCrossRef Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409–47.PubMedCrossRef
47.
go back to reference Eleftheriou KI, Rawal JS, James LE, Payne JR, Loosemore M, Pennell DJ, et al. Bone structure and geometry in young men: the influence of smoking, alcohol intake and physical activity. Bone. 2013;52(1):17–26.PubMedCrossRef Eleftheriou KI, Rawal JS, James LE, Payne JR, Loosemore M, Pennell DJ, et al. Bone structure and geometry in young men: the influence of smoking, alcohol intake and physical activity. Bone. 2013;52(1):17–26.PubMedCrossRef
Metadata
Title
Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases
Authors
Zhuoran Hu
Shuiming Xu
He Lin
Weifeng Ni
Qingyuan Yang
Jun Qi
Keqian Du
Jieruo Gu
Zhiming Lin
Publication date
01-12-2020

Other articles of this Issue 1/2020

BMC Musculoskeletal Disorders 1/2020 Go to the issue